MWNA
AFIB

Marshall Wace North America’s Acutus Medical Inc AFIB Stock Holding History

Marshall Wace North America’s Portfolio AFIB Stock Details AFIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-26,227
Closed -$782K – 1654
2020
Q3 		$782K Buy
+26,227
New +$796K 0.01% 867

Other funds holding AFIB

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $143M AUM 102.52% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AFG
American Financial Group Cincinnati, Ohio $284M AUM 12.01% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
PVI
Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return

Marshall Wace North America's AFIB Position: Q4 2020 in Review

Marshall Wace North America sold out of Acutus Medical Inc (AFIB) in Q4 2020, closing a stake of 26,227 shares — an estimated $782K sold.

Marshall Wace North America first reported a position in AFIB in Q3 2020 and held it in 1 quarter. The position peaked at $782K in Q3 2020. 65 funds tracked by Wall St. Rank hold AFIB as of Q4 2020.

  • Marshall Wace North America reported no remaining Acutus Medical Inc position as of Q4 2020 after selling out during the quarter.
  • Marshall Wace North America sold 26,227 Acutus Medical Inc shares in Q4 2020, an estimated $782K.
  • Marshall Wace North America first reported a position in Acutus Medical Inc in Q3 2020 and held it in 1 quarter.
  • Marshall Wace North America's Acutus Medical Inc position peaked at $782K in Q3 2020.
  • 65 funds tracked by Wall St. Rank held Acutus Medical Inc as of Q4 2020.

Based on Marshall Wace North America's 13F filing for Q4 2020, filed 16 Feb 2021.